3,4-dihydroxyphenylacetic acid has been researched along with 4,7,10,13,16,19-docosahexaenoic acid ethyl ester in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amakawa, M; Kabuto, H; Mankura, M; Mori, A; Yamanushi, TT | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 4,7,10,13,16,19-docosahexaenoic acid ethyl ester
Article | Year |
---|---|
Docosahexaenoic acid ethyl ester enhances 6-hydroxydopamine-induced neuronal damage by induction of lipid peroxidation in mouse striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Docosahexaenoic Acids; Dopamine; Homovanillic Acid; Lipid Peroxidation; Male; Mice; Mice, Inbred ICR; Neostriatum; Oxidative Stress; Oxidopamine; Thiobarbituric Acid Reactive Substances | 2009 |